Cargando…
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU
BACKGROUND: Patients undergoing alcohol withdrawal in the intensive care unit (ICU) often require escalating doses of benzodiazepines and not uncommonly require intubation and mechanical ventilation for airway protection. This may lead to complications and prolonged ICU stays. Experimental studies a...
Autores principales: | Rayner, Samuel G, Weinert, Craig R, Peng, Helen, Jepsen, Stacy, Broccard, Alain F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464179/ https://www.ncbi.nlm.nih.gov/pubmed/22620986 http://dx.doi.org/10.1186/2110-5820-2-12 |
Ejemplares similares
-
Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
por: Lizotte, Riley J, et al.
Publicado: (2014) -
Severe alcohol withdrawal syndrome in ICU: is propofol a safe option?
por: Chico, JI, et al.
Publicado: (2010) -
Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
por: Shah, Poorvi, et al.
Publicado: (2018) -
Dexmedetomidine as an adjunctive treatment for acute asthma
por: Motamed, Hassan, et al.
Publicado: (2021) -
Ketamine: A Potential Adjunct for Severe Benzodiazepine Withdrawal
por: Purcell, Kristen, et al.
Publicado: (2021)